SonoScape Medical Corp (300633) - Net Assets

Latest as of March 2026: CN¥3.26 Billion CNY ≈ $477.54 Million USD

Based on the latest financial reports, SonoScape Medical Corp (300633) has net assets worth CN¥3.26 Billion CNY (≈ $477.54 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.30 Billion ≈ $629.09 Million USD) and total liabilities (CN¥1.04 Billion ≈ $151.55 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore SonoScape Medical Corp (300633) equity growth momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥3.26 Billion
% of Total Assets	75.91%
Annual Growth Rate	18.69%
5-Year Change	38.52%
10-Year Change	353.05%
Growth Volatility	20.8

SonoScape Medical Corp - Net Assets Trend (2012–2025)

This chart illustrates how SonoScape Medical Corp's net assets have evolved over time, based on quarterly financial data. Check SonoScape Medical Corp strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Annual Net Assets for SonoScape Medical Corp (2012–2025)

The table below shows the annual net assets of SonoScape Medical Corp from 2012 to 2025. For live market cap and overall valuation, see SonoScape Medical Corp (300633) total market value.

Year	Net Assets	Change
2025-12-31	CN¥3.26 Billion ≈ $477.40 Million	+4.96%
2024-12-31	CN¥3.11 Billion ≈ $454.83 Million	-1.20%
2023-12-31	CN¥3.15 Billion ≈ $460.35 Million	+14.82%
2022-12-31	CN¥2.74 Billion ≈ $400.92 Million	+16.33%
2021-12-31	CN¥2.36 Billion ≈ $344.64 Million	+75.11%
2020-12-31	CN¥1.34 Billion ≈ $196.81 Million	-4.22%
2019-12-31	CN¥1.40 Billion ≈ $205.49 Million	+7.11%
2018-12-31	CN¥1.31 Billion ≈ $191.84 Million	+23.75%
2017-12-31	CN¥1.06 Billion ≈ $155.02 Million	+47.11%
2016-12-31	CN¥720.11 Million ≈ $105.38 Million	+27.18%
2015-12-31	CN¥566.21 Million ≈ $82.85 Million	+27.29%
2014-12-31	CN¥444.81 Million ≈ $65.09 Million	+21.84%
2013-12-31	CN¥365.08 Million ≈ $53.42 Million	+3.77%
2012-12-31	CN¥351.82 Million ≈ $51.48 Million	--

Equity Component Analysis

This analysis shows how different components contribute to SonoScape Medical Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 549.8% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CN¥1.57 Billion	48.04%
Other Components	CN¥1.70 Billion	51.96%
Total Equity	CN¥3.26 Billion	100.00%

SonoScape Medical Corp Competitors by Market Cap

The table below lists competitors of SonoScape Medical Corp ranked by their market capitalization.

Company	Market Cap
Huapont Life Sciences Co Ltd SHE:002004	$1.30 Billion
One Software Technologies Ltd TA:ONE	$1.30 Billion
Norion Bank ST:NORION	$1.30 Billion
Yihai International Holding Ltd F:YIR	$1.30 Billion
Qingdao NovelBeam Technology Co. Ltd. A SHG:688677	$1.29 Billion
Saha Pathana Inter-Holding PCL BK:SPI	$1.29 Billion
Cogeco Communications Inc TO:CCA	$1.29 Billion
Fujian Dongbai Group Co Ltd SHG:600693	$1.29 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in SonoScape Medical Corp's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 3,108,222,479 to 3,262,490,485, a change of 154,268,006 (5.0%).
Net income of 197,280,077 contributed positively to equity growth.
Dividend payments of 47,233,382 reduced retained earnings.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥197.28 Million	+6.05%
Dividends Paid	CN¥47.23 Million	-1.45%
Other Changes	CN¥4.22 Million	+0.13%
Total Change	CN¥-	4.96%

Book Value vs Market Value Analysis

This analysis compares SonoScape Medical Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.71x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 21.81x to 2.71x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2012-12-31	CN¥0.94	CN¥20.45	x
2013-12-31	CN¥1.03	CN¥20.45	x
2014-12-31	CN¥1.25	CN¥20.45	x
2015-12-31	CN¥1.55	CN¥20.45	x
2016-12-31	CN¥1.99	CN¥20.45	x
2017-12-31	CN¥2.73	CN¥20.45	x
2018-12-31	CN¥3.27	CN¥20.45	x
2019-12-31	CN¥3.51	CN¥20.45	x
2020-12-31	CN¥3.36	CN¥20.45	x
2021-12-31	CN¥5.89	CN¥20.45	x
2022-12-31	CN¥6.40	CN¥20.45	x
2023-12-31	CN¥7.27	CN¥20.45	x
2024-12-31	CN¥7.23	CN¥20.45	x
2025-12-31	CN¥7.54	CN¥20.45	x

Capital Efficiency Dashboard

This dashboard shows how efficiently SonoScape Medical Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 6.05%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 8.54%
• Asset Turnover: 0.52x
• Equity Multiplier: 1.35x
Recent ROE (6.05%) is below the historical average (15.34%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2012	38.91%	26.83%	0.78x	1.86x	CN¥96.55 Million
2013	19.35%	11.93%	0.95x	1.71x	CN¥34.14 Million
2014	29.62%	20.60%	0.75x	1.93x	CN¥87.27 Million
2015	18.70%	15.44%	0.73x	1.65x	CN¥49.25 Million
2016	18.11%	18.13%	0.71x	1.41x	CN¥58.42 Million
2017	17.94%	19.21%	0.74x	1.26x	CN¥84.08 Million
2018	19.27%	20.59%	0.67x	1.40x	CN¥121.52 Million
2019	7.23%	8.10%	0.52x	1.72x	CN¥-38.89 Million
2020	-3.44%	-3.98%	0.52x	1.67x	CN¥-180.76 Million
2021	10.50%	17.12%	0.48x	1.28x	CN¥11.73 Million
2022	13.50%	20.98%	0.50x	1.29x	CN¥95.83 Million
2023	14.45%	21.43%	0.56x	1.20x	CN¥139.84 Million
2024	4.58%	7.07%	0.47x	1.39x	CN¥-168.42 Million
2025	6.05%	8.54%	0.52x	1.35x	CN¥-128.97 Million

Industry Comparison

This section compares SonoScape Medical Corp's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $2,117,310,074
Average return on equity (ROE) among peers: 18.34%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
SonoScape Medical Corp (300633)	CN¥3.26 Billion	38.91%	0.32x	$1.29 Billion
Shanghai Kehua Bio-Engineering Co Ltd (002022)	$380.71 Million	14.82%	0.20x	$407.94 Million
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223)	$12.65 Billion	14.27%	0.24x	$4.04 Billion
Double Medical Technology Inc (002901)	$224.61 Million	43.10%	0.32x	$2.68 Billion
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932)	$115.39 Million	30.85%	0.16x	$519.22 Million
Lepu Medical Tech Beijing (300003)	$2.07 Billion	19.87%	0.08x	$3.54 Billion
INKON Life Technology Co Ltd (300143)	$785.85 Million	7.49%	0.06x	$848.83 Million
Edan Instruments Inc (300206)	$1.16 Billion	1.16%	0.17x	$1.05 Billion
Guangdong Biolight Meditech Co Ltd (300246)	$1.03 Billion	33.51%	0.56x	$596.68 Million
Beijing Leadman Biochemistry Co Ltd (300289)	$1.80 Billion	0.85%	0.07x	$483.21 Million
Sinocare Inc (300298)	$946.01 Million	17.47%	0.11x	$1.36 Billion

About SonoScape Medical Corp

SHE:300633 China Medical Devices

Market Cap

$1.29 Billion

CN¥8.85 Billion CNY

Market Cap Rank

#7835 Global

#1776 in China

Share Price

CN¥20.45

Change (1 day)

+0.59%

52-Week Range

CN¥17.97 - CN¥36.61

All Time High

CN¥60.46